Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AMGN compared with GLUE: revenue, margins and what each company keeps, and the suppliers and customers both name
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
GLUE
Monte Rosa Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
AMGN
Amgen Inc
vs
GLUE
Monte Rosa Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
AMGN
Amgen Inc
Change
460.67
· pre 463.52
· delayed
Mkt cap
$249.4B
Revenue
$10.1B
Q2 FY26
Revenue
$36.8B
FY25
GLUE
Monte Rosa Therapeutics, Inc.
Change
10.39
· pre 10.70
· delayed
Pre-market
Nov 4 '26
delayed
Mkt cap
$888.1M
Revenue
$9M
Q2 FY26
Revenue
$124M
FY25
vs
Compare
Pre-market
Nov 4 '26
delayed
AMGN
Amgen Inc
vs
GLUE
Monte Rosa Therapeutics, Inc.
460.67
pre 463.52
delayed
Price
10.39
pre 10.70
delayed
$249.4B
Mkt cap
$888.1M
Q2 FY26
$10.1B
Revenue
$9M
Q2 FY26
FY25
$36.8B
Revenue
$124M
FY25
Change
Change
AMGN
460.67
vs
GLUE
10.39
Pre-market
Nov 4 '26
delayed
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
GLUE: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only AMGN
12
PODD
Insulet
supplier
CYTK
Cytokinetics
supplier
ARWR
Arrowhead Pharmaceuticals
supplier
LGND
Ligand Pharmaceuticals
supplier
8 more · AMGN chain
›
Shared
0
No disclosed counterparties: GLUE.
Only GLUE
0
None
Role chip = supplier or customer
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
AMGN, solid
GLUE, dashed